γδ T cells: origin and fate, subsets, diseases and immunotherapy
Y Hu, Q Hu, Y Li, L Lu, Z Xiang, Z Yin… - … and Targeted Therapy, 2023 - nature.com
The intricacy of diseases, shaped by intrinsic processes like immune system exhaustion and
hyperactivation, highlights the potential of immune renormalization as a promising strategy …
hyperactivation, highlights the potential of immune renormalization as a promising strategy …
γδ T cells as critical anti-tumor immune effectors
M Arias-Badia, R Chang, L Fong - Nature Cancer, 2024 - nature.com
While the effector cells that mediate anti-tumor immunity have historically been attributed to
αβ T cells and natural killer cells, γδ T cells are now being recognized as a complementary …
αβ T cells and natural killer cells, γδ T cells are now being recognized as a complementary …
Adoptive cell therapy for high grade gliomas using simultaneous temozolomide and intracranial mgmt-modified γδ t cells following standard post-resection …
LB Nabors, LS Lamb, T Goswami, K Rochlin… - Frontiers in …, 2024 - frontiersin.org
Cellular therapies, including chimeric antigen receptor T cell therapies (CAR-T), while
generally successful in hematologic malignancies, face substantial challenges against solid …
generally successful in hematologic malignancies, face substantial challenges against solid …